Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm by Histology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)WithdrawnNCT01336543
What this trial is testing

Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage III Non-small Cell Lung Cancer
Syed Jafri
Large-scale testing (Phase 3)Study completedNCT00379340
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Who this might be right for
Stage III Kidney Wilms TumorStage IV Kidney Wilms Tumor
Children's Oncology Group 395
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Study completedNCT04046614
What this trial is testing

Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology

Who this might be right for
Adenocarcinoma of the Lung
AIO-Studien-gGmbH 56
Not applicableUnknownNCT00639652
What this trial is testing

Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970

Who this might be right for
Carcinoma, Basal Cell
University Hospital Tuebingen 800
Not applicableStudy completedNCT04826952
What this trial is testing

Malignant Testicular Tumors in Children: A Single Institution's 12-year Experience

Who this might be right for
Overall Survival Rates
Chang Gung Memorial Hospital 42
Not applicableUnknownNCT05565677
What this trial is testing

Prognostic Value of Lung Cancer MicroAnatomy in 3D

Who this might be right for
Lung CancerAdenocarcinoma of LungPathology+3 more
Aristotle University Of Thessaloniki 50
Testing effectiveness (Phase 2)Study completedNCT00989664
What this trial is testing

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 60
Not applicableStudy completedNCT02144311
What this trial is testing

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT02279732
What this trial is testing

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin

Who this might be right for
Lung Cancer (NSCLC)
Bristol-Myers Squibb 342
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Not applicableEnded earlyNCT01856036
What this trial is testing

Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers

Who this might be right for
Breast Cancer
Saint John's Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT01224821
What this trial is testing

Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 47
Not applicableStudy completedNCT01370824
What this trial is testing

Clinical Diagnosis of Basal Cell Carcinoma Subtype

Who this might be right for
Basal Cell Carcinoma
Maastricht University Medical Center 150
Not applicableStudy completedNCT05034926
What this trial is testing

Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 212
Not applicableStudy completedNCT01836484
What this trial is testing

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

Who this might be right for
Surgically Staged Endometrial and Cervical CarcinomaCervical Cancer: Invasive Disease, FIGO Stage 1B1 or HigherEndometrial Cancer+3 more
Barts & The London NHS Trust 162
Not applicableStudy completedNCT03610620
What this trial is testing

Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery

Who this might be right for
Basal Cell Carcinoma
Julie Dawson 30
Not applicableStudy completedNCT02285361
What this trial is testing

GIOTRIF rPMS in Korean Patients With NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,272
Next Page